Protagonist Therapeutics Inc (PTGX) last month performance of 5.04% certainly makes it a sizzling prospect
Protagonist Therapeutics Inc (NASDAQ: PTGX) open the trading on Thursday, with a bit cautious approach as it glided -6.13% to $28.35, before settling in for